Global Flu Vaccines Professional Market Insights, Players, Region, Type & Application Analysis 2018-2029

Report ID: ARS12671 | Category: Healthcare | Pages: 129 | Format: PDF | Published Date: December 18,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$4680.00 Multi User-$7900.00

Report Description
View Table of Contents

Report Summary

The global Flu Vaccines market size in 2022 is 8164.8 million US dollars, and it is expected to be 14830.0 million US dollars by 2029, with a compound annual growth rate of 8.90% expected in 2023-2029.

MARKET COMPETITIVE LANDSCAPE:
The main players in the Flu Vaccines market include AstraZeneca (U.K.), BioDiem (Canada), Novasep (France), MerckKGaA (Germany), and Charles River Laboratories (U.K.). The share of the top 3 players in the Flu Vaccines market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Flu Vaccines market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. Quadrivalent Influenza Vaccines accounted for XX% of Flu Vaccines market in 2022. Trivalent Influenza Vaccines share of XX%.
Hospitals and Clinics accounted for XX% of the Flu Vaccines market in 2022. Research Organizations and Academic Institutes accounts for XX%.

The cumulative impact of COVID-19, Russia-Ukraine conflict, and high inflation is expected to have a significant long-term impact on the global Flu Vaccines markets. Ongoing research considers changes in consumer behavior, supply chain disruptions, and government intervention caused by the pandemic. Likewise, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine conflict and its potential impact on the supply-demand balance, pressure on pricing variables, and import, export, and trade. In addition, the report discusses the impact of high inflation on the global economy and details fiscal policies to measure and reduce its impact on demand, supply, cash flows, and currency exchange.

Market Statistics:
Reports provide market sizes and forecasts for multiple major currencies (USD, EUR, JPY, GBP, CNY, etc.); multi-currency support helps organizational leaders make informed decisions. This report takes 2018-2021 as the historical year, 2022 as the base year, 2023 as the semi-forecast year, and 2024-2029 as the full forecast year.

Market Share Analysis:
Market share analysis provides deep insights into the current status of vendors in a particular market space. By comparing suppliers' contributions to total revenue, customer base, and other key metrics, we can give companies a better understanding of their performance and the challenges they face as they compete for market share. The analysis also sheds light on the competitiveness of any given sector in terms of accumulation, diversification of strengths, and consolidation characteristics during the base year studied.

The report provides insights on the following metrics:
Market Penetration: Provides comprehensive information on the market offered by key players
Market Diversification: Provides detailed information on new product launches, greenfield regions, recent developments and investments
Market Trends: A Big Picture of the Cumulative Impact of COVID-19, Russia-Ukraine Conflict, and High Inflation
Competitive assessment and intelligence: Provides an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape and manufacturing capabilities of leading players
Product Development & Innovation: Provides intelligent insights into future technologies, R&D activities, and breakthrough product developments
Market Segmentation: Segment by Type, Application, and Region to provide detailed insights into market information.

Chapter Outline
Chapter 1: Introduces the product overview, market scope, product classification, application, and regional division, and then includes inflation analysis, the impact of the Russo-Ukrainian war on the market, and the global impact of the coronavirus disease (COVID-19).
Chapter 2: Analysis of the competitive environment of Flu Vaccines market participants. This mainly includes the revenue and market share of the top players, along with the players' M&A and expansion in recent years.
Chapter 3: Analyzes the main companies in the Flu Vaccines industry, including their main businesses, products/services, revenue, gross and gross margin.
Chapters 4-6: Segmented the global Flu Vaccines market by type, application and region. Analyze the revenue of market segments from different perspectives.
Chapters 7-15: Provide North America, Europe, China, Japan, Korea, Southeast Asia, India, South America and Middle East & Africa Flu Vaccines market type, application, PEST analysis and players market segmentation data.
Chapter 16: Analyzes the Flu Vaccines business cost, including industrial chain and the proportion of business cost structure.
Chapter 17: Introduces the market dynamics, the trends factors and drivers factors of the market, and the challenges and restraints faced by manufacturers in the industry.
Chapter 18: The main points and conclusions of the report.

Highlights-Regions
North America
Europe
China
Japan
Korea
Southeast Asia
India
South America
Middle East & Africa

Player list
AstraZeneca (U.K.)
BioDiem (Canada)
Novasep (France)
MerckKGaA (Germany)
Charles River Laboratories (U.K.)
uniQure N.V. (Netherlands)
Waisman Biomanufacturing (U.S.)
Creative-Biogene (U.S.)
Aldevron (U.S.)
Oxford Biomedica (U.K.)
Thermo Fisher Scientific Inc (U.S.)
Fujifilm Corporation (Japan)
Spark Therapeutics Inc. (U.S.)
ABL Inc. (U.S.)
Boehringer Ingelheim International GmbH. (Germany)
Brammer Bio (U.S.)
Pfizer Inc. (U.S.)

Types list
Quadrivalent Influenza Vaccines
Trivalent Influenza Vaccines
Whole Virus Vaccines
Split Virus Vaccines
Subunit Vaccines
Live Attenuated Virus Vaccines

Application list
Hospitals and Clinics
Research Organizations and Academic Institutes
Others

Table of Content

1 Flu Vaccines Market Introduction and Overview
1.1 Flu Vaccines Definition
1.2 Market Size Analysis by Types
1.3 Market Size Analysis by Application
1.4 Research Purposes
1.5 Report Timeline
1.6 Economic Analysis of Global Regions
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
2 Market Competition by Manufacturers
2.1 Global Flu Vaccines Revenue and Market Share by Manufacturer
2.2 Manufacturers Flu Vaccines Production Sites, Area Served, Product Types
2.3 Flu Vaccines Market Competitive Situation and Trends
2.3.1 Flu Vaccines Market Concentration Rate
2.3.2 Global Top 5 and Top 10 Players Market Share by Revenue in 2023
2.3.3 Mergers & Acquisitions, Expansion
3 Players Profiles
3.1 AstraZeneca (U.K.)
3.1.1 AstraZeneca (U.K.) Company Profile
3.1.2 Flu Vaccines Product Overview
3.1.3 AstraZeneca (U.K.) Flu Vaccines Market Performance (2018-2023)
3.1.4 AstraZeneca (U.K.) Business Overview
3.2 BioDiem (Canada)
3.2.1 BioDiem (Canada) Company Profile
3.2.2 Flu Vaccines Product Overview
3.2.3 BioDiem (Canada) Flu Vaccines Market Performance (2018-2023)
3.2.4 BioDiem (Canada) Business Overview
3.3 Novasep (France)
3.3.1 Novasep (France) Company Profile
3.3.2 Flu Vaccines Product Overview
3.3.3 Novasep (France) Flu Vaccines Market Performance (2018-2023)
3.3.4 Novasep (France) Business Overview
3.4 MerckKGaA (Germany)
3.4.1 MerckKGaA (Germany) Company Profile
3.4.2 Flu Vaccines Product Overview
3.4.3 MerckKGaA (Germany) Flu Vaccines Market Performance (2018-2023)
3.4.4 MerckKGaA (Germany) Business Overview
3.5 Charles River Laboratories (U.K.)
3.5.1 Charles River Laboratories (U.K.) Company Profile
3.5.2 Flu Vaccines Product Overview
3.5.3 Charles River Laboratories (U.K.) Flu Vaccines Market Performance (2018-2023)
3.5.4 Charles River Laboratories (U.K.) Business Overview
3.6 uniQure N.V. (Netherlands)
3.6.1 uniQure N.V. (Netherlands) Company Profile
3.6.2 Flu Vaccines Product Overview
3.6.3 uniQure N.V. (Netherlands) Flu Vaccines Market Performance (2018-2023)
3.6.4 uniQure N.V. (Netherlands) Business Overview
3.7 Waisman Biomanufacturing (U.S.)
3.7.1 Waisman Biomanufacturing (U.S.) Company Profile
3.7.2 Flu Vaccines Product Overview
3.7.3 Waisman Biomanufacturing (U.S.) Flu Vaccines Market Performance (2018-2023)
3.7.4 Waisman Biomanufacturing (U.S.) Business Overview
3.8 Creative-Biogene (U.S.)
3.8.1 Creative-Biogene (U.S.) Company Profile
3.8.2 Flu Vaccines Product Overview
3.8.3 Creative-Biogene (U.S.) Flu Vaccines Market Performance (2018-2023)
3.8.4 Creative-Biogene (U.S.) Business Overview
3.9 Aldevron (U.S.)
3.9.1 Aldevron (U.S.) Company Profile
3.9.2 Flu Vaccines Product Overview
3.9.3 Aldevron (U.S.) Flu Vaccines Market Performance (2018-2023)
3.9.4 Aldevron (U.S.) Business Overview
3.10 Oxford Biomedica (U.K.)
3.10.1 Oxford Biomedica (U.K.) Company Profile
3.10.2 Flu Vaccines Product Overview
3.10.3 Oxford Biomedica (U.K.) Flu Vaccines Market Performance (2018-2023)
3.10.4 Oxford Biomedica (U.K.) Business Overview
3.11 Thermo Fisher Scientific Inc (U.S.)
3.11.1 Thermo Fisher Scientific Inc (U.S.) Company Profile
3.11.2 Flu Vaccines Product Overview
3.11.3 Thermo Fisher Scientific Inc (U.S.) Flu Vaccines Market Performance (2018-2023)
3.11.4 Thermo Fisher Scientific Inc (U.S.) Business Overview
3.12 Fujifilm Corporation (Japan)
3.12.1 Fujifilm Corporation (Japan) Company Profile
3.12.2 Flu Vaccines Product Overview
3.12.3 Fujifilm Corporation (Japan) Flu Vaccines Market Performance (2018-2023)
3.12.4 Fujifilm Corporation (Japan) Business Overview
3.13 Spark Therapeutics Inc. (U.S.)
3.13.1 Spark Therapeutics Inc. (U.S.) Company Profile
3.13.2 Flu Vaccines Product Overview
3.13.3 Spark Therapeutics Inc. (U.S.) Flu Vaccines Market Performance (2018-2023)
3.13.4 Spark Therapeutics Inc. (U.S.) Business Overview
3.14 ABL Inc. (U.S.)
3.14.1 ABL Inc. (U.S.) Company Profile
3.14.2 Flu Vaccines Product Overview
3.14.3 ABL Inc. (U.S.) Flu Vaccines Market Performance (2018-2023)
3.14.4 ABL Inc. (U.S.) Business Overview
3.15 Boehringer Ingelheim International GmbH. (Germany)
3.15.1 Boehringer Ingelheim International GmbH. (Germany) Company Profile
3.15.2 Flu Vaccines Product Overview
3.15.3 Boehringer Ingelheim International GmbH. (Germany) Flu Vaccines Market Performance (2018-2023)
3.15.4 Boehringer Ingelheim International GmbH. (Germany) Business Overview
3.16 Brammer Bio (U.S.)
3.16.1 Brammer Bio (U.S.) Company Profile
3.16.2 Flu Vaccines Product Overview
3.16.3 Brammer Bio (U.S.) Flu Vaccines Market Performance (2018-2023)
3.16.4 Brammer Bio (U.S.) Business Overview
3.17 Pfizer Inc. (U.S.)
3.17.1 Pfizer Inc. (U.S.) Company Profile
3.17.2 Flu Vaccines Product Overview
3.17.3 Pfizer Inc. (U.S.) Flu Vaccines Market Performance (2018-2023)
3.17.4 Pfizer Inc. (U.S.) Business Overview
4 Global Flu Vaccines Historical and Forecast Market Analysis by Type
4.1 Global Flu Vaccines Revenue and Market Share by Type
4.2 Global Flu Vaccines Revenue Market Forecast by Type (2023-2029)
5 Global Flu Vaccines Historical and Forecast Market Analysis by Application
5.1 Global Flu Vaccines Revenue Market Share by Application (2018-2023)
5.2 Flu Vaccines Revenue Market Forecast by Application (2023-2029)
6 Global Market Growth Trends Analysis
6.1 Global Flu Vaccines Market Size & Forecast (2018-2029)
6.2 Flu Vaccines Growth Trends Analysis by Regions
6.2.1 Flu Vaccines Market Size by Regions: 2018 VS 2023 VS 2029
6.2.2 Flu Vaccines Historic Revenue Market Size by Regions (2018-2023)
6.2.3 Flu Vaccines Forecasted Revenue Market Size by Regions (2023-2029)
6.2.4 North America Flu Vaccines Market Size & Forecast (2018-2029)
6.2.5 Europe Flu Vaccines Market Size & Forecast (2018-2029)
6.2.6 China Flu Vaccines Market Size & Forecast (2018-2029)
6.2.7 Japan Flu Vaccines Market Size & Forecast (2018-2029)
6.2.8 Korea Flu Vaccines Market Size & Forecast (2018-2029)
6.2.9 Southeast Asia Flu Vaccines Market Size & Forecast (2018-2029)
6.2.10 India Flu Vaccines Market Size & Forecast (2018-2029)
6.2.11 South America Flu Vaccines Market Size & Forecast (2018-2029)
6.2.12 Middle East & Africa Flu Vaccines Market Size & Forecast (2018-2029)
7 North America
7.1 North America Flu Vaccines Revenue by Players
7.2 North America Flu Vaccines Revenue by Types
7.3 North America Flu Vaccines Revenue by Applications
7.4 North America Flu Vaccines Revenue, Gross and Gross Margin (2018-2023)
7.5 North America PEST Analysis
8 Europe
8.1 Europe Flu Vaccines Revenue by Players
8.2 Europe Flu Vaccines Revenue by Types
8.3 Europe Flu Vaccines Revenue by Applications
8.4 Europe Flu Vaccines Revenue, Gross and Gross Margin (2018-2023)
8.5 Europe PEST Analysis
9 China
9.1 China Flu Vaccines Revenue by Players
9.2 China Flu Vaccines Revenue by Types
9.3 China Flu Vaccines Revenue by Applications
9.4 China Flu Vaccines Revenue, Gross and Gross Margin (2018-2023)
9.5 China PEST Analysis
10 Japan
10.1 Japan Flu Vaccines Revenue by Players
10.2 Japan Flu Vaccines Revenue by Types
10.3 Japan Flu Vaccines Revenue by Applications
10.4 Japan Flu Vaccines Revenue, Gross and Gross Margin (2018-2023)
10.5 Japan PEST Analysis
11 Korea
11.1 Korea Flu Vaccines Revenue by Players
11.2 Korea Flu Vaccines Revenue by Types
11.3 Korea Flu Vaccines Revenue by Applications
11.4 Korea Flu Vaccines Revenue, Gross and Gross Margin (2018-2023)
11.5 Korea PEST Analysis
12 Southeast Asia
12.1 Southeast Asia Flu Vaccines Revenue by Players
12.2 Southeast Asia Flu Vaccines Revenue by Types
12.3 Southeast Asia Flu Vaccines Revenue by Applications
12.4 Southeast Asia Flu Vaccines Revenue, Gross and Gross Margin (2018-2023)
12.5 Southeast Asia PEST Analysis
13 India
13.1 India Flu Vaccines Revenue by Players
13.2 India Flu Vaccines Revenue by Types
13.3 India Flu Vaccines Revenue by Applications
13.4 India Flu Vaccines Revenue, Gross and Gross Margin (2018-2023)
13.5 India PEST Analysis
14 South America
14.1 South America Flu Vaccines Revenue by Players
14.2 South America Flu Vaccines Revenue by Types
14.3 South America Flu Vaccines Revenue by Applications
14.4 South America Flu Vaccines Revenue, Gross and Gross Margin (2018-2023)
14.5 South America PEST Analysis
15 Middle East & Africa
15.1 Middle East & Africa Flu Vaccines Revenue by Players
15.2 Middle East & Africa Flu Vaccines Revenue by Types
15.3 Middle East & Africa Flu Vaccines Revenue by Applications
15.4 Middle East & Africa Flu Vaccines Revenue, Gross and Gross Margin (2018-2023)
15.5 Middle East & Africa PEST Analysis
16 Flu Vaccines Business Cost Analysis
16.1 Proportion of Business Cost Structure
16.1.1 Labor Cost
16.1.2 Operating Expenses
16.2 Flu Vaccines Industrial Chain Analysis
17 Flu Vaccines Industry Dynamic Analysis
17.1 Flu Vaccines Market Trends Analysis
17.2 Flu Vaccines Market Drivers Analysis
17.3 Flu Vaccines Market Challenges Analysis
17.4 Flu Vaccines Market Restraints Analysis
18 Research Findings and Conclusion

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Flu Vaccines Professional Market Insights, Players, Region, Type & Application Analysis 2018-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?